Skip to content
AwardedSpainGoods€4,079,244

Suministro de fármacos exclusivos con principios activos sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir, bulevirtida, remdesivir, sacituzumab govitecan, aztreonam para inhalación, amfotericina b liposomal, bictegravir/emtricitabina/tenofovir alafenamida, emtricitabina/rilpivirina/tenofovir alafenamida, elvitegravir/cobicistat/emtricitabina/tenofovir alafenamida,emtricitabina/rilpiviri

Published
Published 31 October 2025

Overview

Suministro de fármacos exclusivos con principios activos sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir, bulevirtida, remdesivir, sacituzumab govitecan, aztreonam para inhalación, amfotericina b liposomal, bictegravir/emtricitabina/tenofovir alafenamida, emtricitabina/rilpivirina/tenofovir alafenamida, elvitegravir/cobicistat/emtricitabina/tenofovir alafenamida,emtricitabina/rilpivirina/tenofovir disoproxilo y emtricitabina/tenofovir alafenamida, del laboratorio farmacéutico gilead sciences, s.l, para los centros dependientes del servicio murciano de salud

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€4,079,244
Procedure
Direct
Published
31 October 2025
Classification (CPV)
Antibacterials for systemic useAntimycotics for systemic useAntivirals for systemic useAntineoplastic agents

Award outcome

Awarded value
€23,351,847
Award date
2 October 2025
Winner
  • GILEAD SCIENCES, S.L

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    31 October 2025

Contracting authority

  • Servicio Murciano de Salud - Junta de Compras

    Procuring entity

    Espinardo, Spain

    ID_PLATAFORMA: 41261690169929

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de fármacos exclusivos con principios activos sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir, bulevirtida, remdesivir, sacituzumab govitecan, aztreonam para inhalación, amfotericina b liposomal, bictegravir/emtricitabina/tenofovir alafenamida, emtricitabina/rilpivirina/tenofovir alafenamida, elvitegravir/cobicistat/emtricitabina/tenofovir alafenamida,emtricitabina/rilpiviri — won by GILEAD SCIENCES, S.L — Skim